Tokyo, Feb. 26 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060748) titled 'A study examining daily life characteristics in adults aged 70 years and older with concerns about their memory' on Feb. 26.

Study Type: Observational

Primary Sponsor: Institute - Kobe University

Condition: Condition - Subjective Cognitive Decline Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - The purpose of this study is to investigate the association between subjective cognitive decline (SCD) and instrumental activities of daily living (IADL) in community-dwelling older adults. As a secondary analysis, the characteristics of IADL according to the presence or absence of discrepancy between subjective cognitive assessment and objective cognitive function will be descriptively examined. Basic objectives2 - Others

Eligibility: Age-lower limit - 70 years-old = Gender - Male and Female Key inclusion criteria - Community-dwelling adults aged 70 years or older Individuals who are able to walk independently or are independent in mobility Individuals who can understand the study and provide informed consent Key exclusion criteria - Individuals who meet the contraindications or exclusion criteria for Mirevo, including those with severe ophthalmologic diseases that prevent eye tracking or visual recognition of the projected screen.

Specifically: Individuals with blindness, low vision, glaucoma, retinitis pigmentosa, diabetic retinopathy, age-related macular degeneration, visual field defects, central scotoma, visual field loss, color vision disorders, or light perception disorders.

Individuals with active neurological or psychiatric diseases, including multiple sclerosis, amyotrophic lateral sclerosis, Guillain-Barre syndrome, encephalitis or meningitis, schizophrenia, severe depression, bipolar disorder, or severe personality disorders.

Individuals diagnosed with Alzheimer's disease, vascular dementia, dementia with Lewy bodies, frontotemporal dementia, or mild cognitive impairment (MCI) by a medical institution. Target Size - 94

Recruitment Status: Recruitment status - Open public recruiting Date of protocol fixation - 2026 Year 01 Month 15 Day Date of IRB - 2026 Year 01 Month 15 Day Anticipated trial start date - 2026 Year 02 Month 17 Day Last follow-up date - 2026 Year 10 Month 31 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000069501

Disclaimer: Curated by HT Syndication.